VX-864

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VX-864, covering 2022-05-26 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of VX-864 in Participants With the PiZZ Genotype [Phase 2]